Skip to main content

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Entrada Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of TRDA: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders6277+15
Shares26.3M26.0M−254.5K (−1.0%)
Value$396.6M$368.8M−$27.8M (−7.0%)

New holders (18)

Institutions that held Entrada Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to TRDA in Q1 2024
InstitutionSharesValue% of portfolio
Citadel Advisors LLC69,676$987.3K0.00%
Marshall Wace, LLP51,723$732.9K0.00%
Squarepoint Ops LLC34,101$483.2K0.00%
Winton Group Ltd32,555$461.3K0.03%
Connor, Clark & Lunn Investment Management Ltd.30,784$436.2K0.00%
Schonfeld Strategic Advisors LLC28,951$410.2K0.00%
New York Life Investment Management LLC25,914$367.2K0.00%
Martingale Asset Management L P18,452$261.5K0.01%
Man Group plc16,809$238.2K0.00%
Harbor Capital Advisors, Inc.14,543$206.0K0.03%
Arrowstreet Capital, Limited Partnership14,307$203.0K0.00%
Cornercap Investment Counsel Inc13,143$186.2K0.03%
PDT Partners, LLC12,553$177.9K0.02%
Acadian Asset Management LLC5,685$79.0K0.00%
New York State Teachers Retirement System1,915$27.0K0.00%
GAMMA Investing LLC40$5670.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC4$560.00%
CWM, LLC1$00.00%

Sold out (3)

Institutions that held Entrada Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of TRDA in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
72 Investment Holdings, LLC172,600$2.60M
Mirae Asset Global Investments Co., Ltd.10,874$164.1K
State of Wyoming5,932$89.5K